Close

Citi Says Avantor (AVTR) Selloff is 'Overdone', Upgrades to Buy

October 5, 2022 9:45 AM EDT
Get Alerts AVTR Hot Sheet
Price: $21.81 -0.05%

Rating Summary:
    20 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 17 | New: 52
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Citi analyst Patrick Donnelly upgraded shares of Avantor (NYSE: AVTR) to Buy from Neutral with a $28 per share price target.

The upgrade comes as Avantor shares trade over 30% lower since the end of July. Donnelly described this underperformance as “significant,” and sees disconnected valuation.

“We believe current valuation appropriately accounts for the M&A revenue shortfall and downside risk to core numbers. Further, we see a potential clearing event for AVTR stock if management formally sets a more appropriate floor for FY23 organic revenue growth guidance on the earnings call on the lower end of the company’s long-term +4-6% organic growth target range,” Donnelly said in a client note.

On the other hand, the analyst cut the rating on Sotera Health Company (NASDAQ: SHC) to Neutral from Buy with the price target going to $9 from $25. The upgrade move comes on the back of a recent jury verdict in the Kamuda trial in Illinois that went against SHC with the company ordered to pay about $100 million for damages associated with decades of toxic air pollution near its former Willowbrook sterilization facility.

“The loss of the Kamuda trial appeal and subsequent trial losses would have a materially negative impact on Sotera’s balance sheet and liquidity position moving forward, in our view. Given the increased risk we move to the sidelines,” Donnelly further explained in a note.

SHC shares are down over 8% today while Avantor stock is up more than 1%.

By Senad Karaahmetovic



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Downgrades, Hot Comments, Hot List, Upgrades

Related Entities

Citi, Earnings, Senad Karaahmetovic